Home  >  Products  >  LILRA4 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 ) Blocking Peptide (the C terminal of LILRA4)(100ug)
LILRA4 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 ) Blocking Peptide (the C terminal of LILRA4)(100ug)

LILRA4 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 ) Blocking Peptide (the C terminal of LILRA4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LILRA4 Antibody (ARP65912_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65912
Size: 100ug
Weight: 50kDa
Gene: 23547
Format: Lyophilized powder
Target: This gene encodes an immunoglobulin-like cell surface protein preferentially expressed in plasmacytoid dendritic cells (PDCs). This gene is highly expressed in PDCs, and is found to be rapidly down-regulated by interleukin 3 (IL3). This gene is one of the 19 highly related genes that form a leukocyte receptor gene cluster (LRC) at chromosomal region 19q13.4.
Alternative names: CD85g; ILT7; MGC129597; MGC129598
See Full Product Listings >